Intellipharmaceutics International Inc IPCIQ

Healthcare Biotechnology

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

GREY:IPCIQ - Post by User

Intellipharmaceutics International Inc > Pill deserved the no vote but it's an easy fix.

<< Previous

Bullboard Posts

Next >>

Comment by bigkaganon Jan 20, 2020 12:15am

190 Views

Post# 30572169

RE:Pill deserved the no vote but it's an easy fix.

you don't know nothing, IPCI has already done what FDA wanted them to do, it's impossible to improve the pill any further, FDA has to approve it as it is

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Jan. 10, 2025)